semaglutide advisory committee FDA Convenes on Peptides This Week, Understanding What Reclassification Mean RFK Jr fires all 17

Changes in clarity, color, or texture often indicate degradation

trial, in which patients were switched from other GLP-1 RAs to weekly subcutaneous semaglutide, indicating that semaglutide may be the GLP-1 RA of choice in patients with MASLD, with daily preparations of semaglutide more effective than the weekly ones

It inhibits the delayed rectifier potassium current responsible for repolarization, acting in a reverse-use-dependent manner

Pochini, L., Scalise, M., Galluccio, M

Gastrointestinal claims involving Mounjaro and Zepbound follow a similar legal theory, failure to warn, but are pursued against Eli Lilly, not Novo Nordisk